Sporala red del conocimiento
EN
Universidad Nacional de Colombia

Bogotá - Ciencias - Doctorado en Ciencias Farmacéuticas · 2024

Síntesis y cribado de péptidos modificados derivados de lactoferricina bovina como fármacos citotóxicos contra líneas de cáncer de colon

Research on anticancer peptide drugs has gained interest due to their potency and selectivity. Bovine Lactoferricin (LfcinB) and derived peptides, as used in this study, have shown cytotoxic activity against breast cancer. Therefore, their effect on colon cancer was evaluated, specifically on Caco-2 and HT-29 cell lines, with the latter being more resistant. Two hit peptides, LfcinB (21-25)Pal and 26[F] LfcinB (20-30)2, were identified. Libraries of monomeric and dimeric peptides were constructed from these, resulting in 34 molecules. Their cytotoxic effect was assessed on colon cancer cell lines. This process allowed the identification of key amino acids in the sequence necessary for cytotoxic activity and modifications of interest to enhance it. Fifteen molecules exhibited inhibitory concentrations (IC50) below 200 μg/mL against colon cancer cell lines, with eight considered optimized peptides due to improved activity and selectivity. They remained active in colon cancer cell lines from 2 to 72 hours, showing cytotoxicity in prostate, cervical, and breast cancer lines. Optimized peptides, particularly 3, 19, and LfcinB (21-25)Pal, induced cell death in HT-29 cells primarily through the apoptotic pathway, causing mitochondrial membrane depolarization, caspase overexpression, and morphological changes such as rounding and cell contraction. The toxicity of optimized peptides 3, 19, LfcinB (21-25)Pal, and LfcinB (21-25)Pal2 was evaluated in Galleria mellonella, finding lethal doses (LD50) >100mg/kg. Moreover, peptide 19 toxicity was assessed in CD1 mice through the Irwin test, revealing central nervous system effects with LD50 between 70mg/kg and 140mg/kg. Lastly, the zebrafish model determined the CL50 of this optimized peptide to be between 20-25 μg/mL. It was also found that this optimized peptide exhibited lower in vivo toxicity than the sequence-derived peptide (hit). Based on the results, eight optimized peptides were identified, with peptides 3, 19, and LfcinB (21-25)Pal standing out as candidates for further studies in developing treatments for colon cancer.

Texto completo 199 páginas con texto

Leer la tesis completa Ficha en el repositorio

Contenido

Tesauro de su biblioteca